Industrials, Technology, Healthcare Jul 20, 2021 08:45 PM (GMT+8)
Guoxin Health announced that the company plans to purchase 5.05% equity of Yiyong technology held by Shengshi Luowei in cash at a transaction price of 24.6 million yuan. After the completion of the above transfer, Guoxin health plans to invest 57.4 million yuan in cash to increase the capital of the target company. After the completion of the capital increase, the shareholding ratio of Guoxin health to the target company will reach 10.02%. Yiyong technology is a technology enterprise that carries out business around the tumor big data ecosystem.
This text is a result of machine translation.